» Articles » PMID: 23086985

Cell-based Interventions for Therapeutic Angiogenesis: Review of Potential Cell Sources

Overview
Journal Vascular
Date 2012 Oct 23
PMID 23086985
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Alternative therapies are currently being developed to treat patients with chronic limb ischemia who are unable to be revascularized in order to avoid amputation. Cell-based therapy using mononuclear cells is gaining attention as many clinical trials are currently underway. We review cell differentiation along with the different potential cell sources for use in therapeutic angiogenesis.

Citing Articles

De novo copy number variations in candidate genomic regions in patients of severe autism spectrum disorder in Vietnam.

Bui H, Huy Do D, Ly H, Tran K, Le H, Nguyen K PLoS One. 2024; 19(3):e0290936.

PMID: 38451970 PMC: 10919600. DOI: 10.1371/journal.pone.0290936.


CD34-Structure, Functions and Relationship with Cancer Stem Cells.

Radu P, Zurzu M, Paic V, Bratucu M, Garofil D, Tigora A Medicina (Kaunas). 2023; 59(5).

PMID: 37241170 PMC: 10220851. DOI: 10.3390/medicina59050938.


Supramolecular hydrogels encapsulating bioengineered mesenchymal stem cells for ischemic therapy.

Hwang B, Kim Y, Kim M, Han S, Bok S, Park K RSC Adv. 2022; 8(34):18771-18775.

PMID: 35539688 PMC: 9080606. DOI: 10.1039/c8ra00464a.


CD34 circulating cells display signs of immune activation in patients with acute coronary syndrome.

Riesinger L, Saemisch M, Nickmann M, Methe H Heart Vessels. 2018; 33(12):1559-1569.

PMID: 30003322 DOI: 10.1007/s00380-018-1220-7.


A Murine Model of Hind Limb Ischemia to Study Angiogenesis and Arteriogenesis.

Yu J, Dardik A Methods Mol Biol. 2018; 1717:135-143.

PMID: 29468589 PMC: 5993192. DOI: 10.1007/978-1-4939-7526-6_11.


References
1.
Lorenz E, Uphoff D, Reid T, Shelton E . Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst. 1951; 12(1):197-201. View

2.
Hristov M, Weber C . Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med. 2004; 8(4):498-508. PMC: 6740289. DOI: 10.1111/j.1582-4934.2004.tb00474.x. View

3.
Kawamoto A, Gwon H, Iwaguro H, Yamaguchi J, Uchida S, Masuda H . Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001; 103(5):634-7. DOI: 10.1161/01.cir.103.5.634. View

4.
La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M . Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol. 2008; 131(2):267-82. DOI: 10.1007/s00418-008-0519-3. View

5.
Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P . Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. 2006; 116(7):1865-77. PMC: 1483161. DOI: 10.1172/JCI27019. View